Purple Biotech (PPBT) director reports large RSU and option holdings
Rhea-AI Filing Summary
PURPLE BIOTECH LTD. director Shai S. Lankry filed an initial ownership report showing a sizable equity position. He holds 3,550,000 Ordinary Shares, including 3,254,167 unvested restricted stock units that settle in shares or ADSs. He also holds stock options to purchase 3,000,000 Ordinary Shares at an exercise price of $0.01359375 per share and options to purchase 3,550,000 Ordinary Shares at $0.00309375 per share, both vesting over several years and expiring in 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Lankry Shai S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 6,550,000 shares (Direct);
Ordinary Shares — 3,550,000 shares (Direct)
Footnotes (3)
- F1. Includes 3,254,167 unvested restricted stock units ("RSUs"), each with respect to one ordinary share, no par value, per share ("Ordinary Shares"), of Purple Biotech Ltd. (the "Issuer"). The RSUs are subject to time-based vesting conditions and are settled in Ordinary Shares. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares
- F2. Represents stock option to purchase 3,000,000 Ordinary Shares (equivalent to 1,500 ADSs), issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan. The options to purchase 1,000,000 Ordinary Shares will vest on April 29, 2026, with the remaining 2,000,000 Ordinary Shares vesting in equal quarterly installments until April 29, 2028. The exercise price of this stock option is $0.01359375 per Ordinary Share and the option expires on April 29, 2030.
- F3. Represents stock option to purchase 3,550,000 Ordinary Shares (equivalent to 1,775 ADSs), issued to the reporting person pursuant to the Issuer's 2016 Equity-Based Incentive Plan. Options to purchase 295,833 Ordinary Shares are vested and exercisable, with the remaining options to purchase 3,254,167 Ordinary Shares vesting in equal quarterly installments until October 21, 2028. The exercise price of this stock option is $0.00309375 per Ordinary Share and the option expires on October 21, 2030.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 filing for PURPLE BIOTECH (PPBT) disclose about Shai S. Lankry?
The filing shows director Shai S. Lankry’s initial equity holdings in Purple Biotech. It details Ordinary Shares, unvested restricted stock units, and substantial stock option positions with specific exercise prices, vesting schedules, and expiration dates under the company’s 2016 Equity-Based Incentive Plan.
How many unvested RSUs does Shai S. Lankry hold in PURPLE BIOTECH (PPBT)?
Shai S. Lankry holds 3,254,167 unvested restricted stock units in Purple Biotech. Each RSU represents one Ordinary Share, subject to time-based vesting, and is settled in Ordinary Shares, which may be represented by American Depositary Shares according to the disclosure footnotes.
What stock option grants are reported for Shai S. Lankry at PURPLE BIOTECH (PPBT)?
He has stock options to purchase 3,000,000 Ordinary Shares and separate options to purchase 3,550,000 Ordinary Shares. These options were issued under the 2016 Equity-Based Incentive Plan with detailed vesting schedules, exercise prices, and expiration dates extending to April and October 2030.
What are the exercise prices of Shai S. Lankry’s PURPLE BIOTECH (PPBT) stock options?
One option grant carries an exercise price of $0.01359375 per Ordinary Share, while another has an exercise price of $0.00309375 per Ordinary Share. Both sets of options relate to Ordinary Shares issued under Purple Biotech’s 2016 Equity-Based Incentive Plan.
When do Shai S. Lankry’s PURPLE BIOTECH (PPBT) stock options expire?
The 3,000,000-share stock option grant expires on April 29, 2030, while the 3,550,000-share option grant expires on October 21, 2030. Both grants have multi-year vesting schedules, with portions vesting in quarterly installments through those expiration dates.
How many of Shai S. Lankry’s PURPLE BIOTECH (PPBT) options are already vested?
For the 3,550,000-share option grant, options to purchase 295,833 Ordinary Shares are vested and exercisable. The remaining options to purchase 3,254,167 Ordinary Shares vest in equal quarterly installments until October 21, 2028, according to the Form 3 footnote disclosure.